TherapeuticsMD (TXMD) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free TXMD Stock Alerts $1.88 -0.01 (-0.53%) (As of 04/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media TherapeuticsMD Short Interest DataCurrent Short Volume45,900 sharesPrevious Short Volume45,200 sharesChange Vs. Previous Month+1.55%Dollar Volume Sold Short$89,505.00Short Interest Ratio / Days to Cover2.0Last Record DateApril 15, 2024Outstanding Shares11,530,000 sharesFloat Size11,090,000 sharesShort Percent of Float0.41%Today's Trading Volume15,693 sharesAverage Trading Volume21,008 sharesToday's Volume Vs. Average75% Short Selling TherapeuticsMD ? Sign up to receive the latest short interest report for TherapeuticsMD and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTXMD Short Interest Over TimeTXMD Days to Cover Over TimeTXMD Percentage of Float Shorted Over Time Ad PharmaStocksTodayNYSE Spotlight & A Soaring Biotech Breakthrough You Need to SeeThe CEO of a groundbreaking biotech firm we’ve been closely following made headlines with a stunning appearance on the NY Stock Exchange floor, unveiling news that's too big to ignore. But here’s why this matters to you: in the world of investing, timing is everything. Get instant access to our exclusive report TherapeuticsMD Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202445,900 shares $89,505.00 +1.6%0.4%2 $1.95 3/31/202445,200 shares $103,508.00 -4.6%0.4%2.1 $2.29 3/15/202447,400 shares $113,760.00 +15.9%0.5%2.4 $2.40 2/29/202440,900 shares $98,160.00 -18.9%0.4%1.8 $2.40 2/15/202450,400 shares $112,896.00 -8.2%0.5%2.6 $2.24 1/31/202454,900 shares $124,074.00 -57.7%0.5%2.5 $2.26 Get the Latest News and Ratings for TXMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024129,800 shares $295,944.00 -39.8%1.3%5.6 $2.28 12/31/2023215,600 shares $485,100.00 +143.1%N/A9.3 $2.25 12/15/202388,700 shares $207,558.00 -56.8%0.9%3.9 $2.34 11/30/2023205,400 shares $529,932.00 -4.1%2.0%9.4 $2.58 11/15/2023214,100 shares $505,276.00 -13.8%2.1%10.7 $2.36 10/31/2023248,500 shares $529,305.00 +162.4%2.4%13.1 $2.13 10/15/202394,700 shares $240,538.00 -8.7%0.9%4.8 $2.54 9/30/2023103,700 shares $313,174.00 -71.9%1.1%5.4 $3.02 9/15/2023369,000 shares $1.23 million +21.3%3.8%18.2 $3.33 8/31/2023304,300 shares $1.15 million -5.1%3.1%13.2 $3.79 8/15/2023320,700 shares $1.23 million -4.7%3.3%13.1 $3.84 7/31/2023336,400 shares $1.37 million -7.9%3.6%11.4 $4.06 7/15/2023365,100 shares $1.43 million +0.3%3.9%11.1 $3.93 6/30/2023364,200 shares $1.50 million +21.4%3.9%10.2 $4.12 6/15/2023300,100 shares $1.15 million +1.7%3.2%8 $3.84 5/31/2023295,100 shares $1.22 million -5.6%3.1%7.8 $4.15 5/15/2023312,600 shares $1.37 million -8.7%3.3%8.1 $4.39 4/30/2023342,400 shares $1.21 million +3.5%3.7%10 $3.54 4/15/2023330,900 shares $1.20 million +4.3%3.6%8.8 $3.62 3/31/2023317,200 shares $1.19 million +20.2%3.4%8 $3.75 3/15/2023263,800 shares $962,870.00 +10.4%3.0%5.5 $3.65 2/28/2023239,000 shares $1.19 million -11.2%2.7%1.9 $4.96 2/15/2023269,000 shares $1.38 million -5.4%3.2%2.1 $5.13 1/31/2023284,400 shares $1.50 million -12.1%3.2%2.1 $5.27 1/15/2023323,500 shares $1.75 million -4.1%3.8%2.4 $5.40 12/30/2022337,200 shares $1.88 million -26.2%4.0%2.5 $5.59 12/15/2022457,000 shares $3.03 million +46.8%5.4%3.4 $6.63 11/30/2022311,300 shares $1.43 million -19.5%3.7%2.4 $4.58 11/15/2022386,500 shares $2.29 million +12.9%4.6%5.4 $5.93 10/31/2022342,400 shares $2.17 million +2.4%4.1%2.7 $6.33 10/15/2022334,400 shares $2.15 million -3.3%4.0%1.2 $6.44 9/30/2022345,900 shares $2.30 million -5.9%4.2%0.8 $6.64 9/15/2022367,600 shares $2.87 million -11.2%4.4%0.6 $7.80 8/31/2022413,800 shares $4.10 million -33.3%5.0%0.5 $9.91NYSE Spotlight & A Soaring Biotech Breakthrough You Need to See (Ad)The CEO of a groundbreaking biotech firm we’ve been closely following made headlines with a stunning appearance on the NY Stock Exchange floor, unveiling news that's too big to ignore. But here’s why this matters to you: in the world of investing, timing is everything. Get instant access to our exclusive report TXMD Short Interest - Frequently Asked Questions What is TherapeuticsMD's current short interest? Short interest is the volume of TherapeuticsMD shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 45,900 shares of TXMD short. 0.41% of TherapeuticsMD's shares are currently sold short. Learn More on TherapeuticsMD's current short interest. What is a good short interest ratio for TherapeuticsMD? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TXMD shares currently have a short interest ratio of 2.0. Learn More on TherapeuticsMD's short interest ratio. What is a good short interest percentage for TherapeuticsMD? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.41% of TherapeuticsMD's floating shares are currently sold short. Is TherapeuticsMD's short interest increasing or decreasing? TherapeuticsMD saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 45,900 shares, an increase of 1.5% from the previous total of 45,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TherapeuticsMD's float size? TherapeuticsMD currently has issued a total of 11,530,000 shares. Some of TherapeuticsMD's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TherapeuticsMD currently has a public float of 11,090,000 shares. How does TherapeuticsMD's short interest compare to its competitors? 0.41% of TherapeuticsMD's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to TherapeuticsMD: Lisata Therapeutics, Inc. (0.24%), MEI Pharma, Inc. (0.34%), Synlogic, Inc. (0.53%), Indaptus Therapeutics, Inc. (1.46%), Onconova Therapeutics, Inc. (0.12%), Lumos Pharma, Inc. (5.83%), Bullfrog AI Holdings, Inc. (5.49%), Biora Therapeutics, Inc. (4.33%), Vincerx Pharma, Inc. (8.91%), Cumberland Pharmaceuticals Inc. (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short TherapeuticsMD stock? Short selling TXMD is an investing strategy that aims to generate trading profit from TherapeuticsMD as its price is falling. TXMD shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TherapeuticsMD? A short squeeze for TherapeuticsMD occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TXMD, which in turn drives the price of the stock up even further. How often is TherapeuticsMD's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TXMD, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Lisata Therapeutics Short Interest MEI Pharma Short Interest Synlogic Short Interest Indaptus Therapeutics Short Interest Onconova Therapeutics Short Interest Lumos Pharma Short Interest Bullfrog AI Short Interest Biora Therapeutics Short Interest Vincerx Pharma Short Interest Cumberland Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TXMD) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTrump’s last act as President Porter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTIThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace